These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1342582)

  • 21. A comparative evaluation of pilocarpine 1% and clonidine 0.125% versus timolol 0.5%.
    Sihota R; Agarwal HC; Rajashekar YL
    Indian J Ophthalmol; 1996 Jun; 44(2):87-9. PubMed ID: 8916595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-masked randomized comparison of the efficacy and safety of unoprostone with timolol and betaxolol in patients with primary open-angle glaucoma including pseudoexfoliation glaucoma or ocular hypertension. 6 month data.
    Nordmann JP; Mertz B; Yannoulis NC; Schwenninger C; Kapik B; Shams N;
    Am J Ophthalmol; 2002 Jan; 133(1):1-10. PubMed ID: 11755834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term intraocular pressure-lowering efficacy and safety of timolol maleate gel-forming solution 0.5% compared with Timoptic XE 0.5% in a 12-month study.
    Schenker HI; Silver LH
    Am J Ophthalmol; 2000 Aug; 130(2):145-50. PubMed ID: 11004287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and tolerability of fixed-combination bimatoprost/timolol versus fixed-combination dorzolamide/brimonidine/timolol in patients with primary open-angle glaucoma or ocular hypertension: a multicenter, prospective, crossover study.
    García-López A; Paczka JA; Jiménez-Román J; Hartleben C
    BMC Ophthalmol; 2014 Dec; 14():161. PubMed ID: 25527295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patient selection in the Timpilo Study.
    Loewenstein A; Lazar M
    Arch Ophthalmol; 1993 Oct; 111(10):1313. PubMed ID: 8280287
    [No Abstract]   [Full Text] [Related]  

  • 26. Twenty-four hour intraocular pressure reduction with latanoprost compared with pilocarpine as third-line therapy in exfoliation glaucoma.
    Konstas AG; Lake S; Maltezos AC; Holmes KT; Stewart WC
    Eye (Lond); 2001 Feb; 15(Pt 1):59-62. PubMed ID: 11318297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Additive intraocular pressure reduction effect of fixed combination of maleate timolol 0.5%/dorzolamide 2% (Cosopt) on monotherapy with latanoprost (Xalatan) in patients with elevated intraocular pressure: a prospective, 4-week, open-label, randomized, controlled clinical trial.
    Hatanaka M; Reis A; Sano ME; Susanna R
    J Glaucoma; 2010; 19(5):331-5. PubMed ID: 19730119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative study between timolol and pilocarpine in the treatment of open-angle glaucoma (author's transl)].
    Schiffer HP
    Klin Monbl Augenheilkd; 1979 Jul; 175(1):91-4. PubMed ID: 491473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two-year safety study of dorzolamide as monotherapy and with timolol and pilocarpine. Dorzolamide Safety Study Group.
    Adamsons IA; Polis A; Ostrov CS; Boyle JE
    J Glaucoma; 1998 Dec; 7(6):395-401. PubMed ID: 9871861
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The IOP-lowering effect of timolol in simple and capsular glaucoma. A multicenter study in Finland.
    Takki KK; Klemetti A; Valle O
    Graefes Arch Clin Exp Ophthalmol; 1982; 218(2):83-7. PubMed ID: 7075965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Long-term study of chronic glaucoma treated with beta blockers (timolol)].
    Steinbach PD; Gruia DG
    Klin Monbl Augenheilkd; 1987 Jun; 190(6):534-8. PubMed ID: 3114544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The safety and efficacy of brinzolamide 1%/timolol 0.5% fixed combination versus dorzolamide 2%/timolol 0.5% in patients with open-angle glaucoma or ocular hypertension.
    Manni G; Denis P; Chew P; Sharpe ED; Orengo-Nania S; Coote MA; Laganovska G; Volksone L; Zeyen T; Filatori I; James J; Aung T
    J Glaucoma; 2009; 18(4):293-300. PubMed ID: 19365194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Brimonidine 0.2% given two or three times daily versus timolol maleate 0.5% in primary open-angle glaucoma.
    Konstas AG; Stewart WC; Topouzis F; Tersis I; Holmes KT; Stangos NT
    Am J Ophthalmol; 2001 Jun; 131(6):729-33. PubMed ID: 11384568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timolol 0.5%/dorzolamide 2% fixed combination vs timolol maleate 0.5% and unoprostone 0.15% given twice daily to patients with primary open-angle glaucoma or ocular hypertension.
    Day DG; Schacknow PN; Wand M; Sharpe ED; Stewart JA; Leech J; Stewart WC
    Am J Ophthalmol; 2003 Feb; 135(2):138-43. PubMed ID: 12566015
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison between pilocarpine and timolol on diurnal pressures in open-angle glaucoma.
    Hass I; Drance SM
    Arch Ophthalmol; 1980 Mar; 98(3):480-1. PubMed ID: 7189114
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of elevated intraocular pressure with concurrent levobunolol and pilocarpine.
    David R; Ober M; Masi R; Elman J; Novack GD; Sears ML; Batoosingh AL
    Can J Ophthalmol; 1987 Jun; 22(4):208-11. PubMed ID: 2886200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical experience with a fixed dose combination therapy of timolol and pilocarpine used twice daily in the management of chronic open angle glaucoma.
    Moriarty AP; Dowd TC; Trimble RB
    Eye (Lond); 1994; 8 ( Pt 4)():410-3. PubMed ID: 7821462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Michaud JE; Friren B;
    Am J Ophthalmol; 2001 Aug; 132(2):235-43. PubMed ID: 11476685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Topical dorzolamide 2%/timolol 0.5%: a review of its use in the treatment of open-angle glaucoma.
    Ormrod D; McClellan K
    Drugs Aging; 2000 Dec; 17(6):477-96. PubMed ID: 11200308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%.
    Orengo-Nania S; Landry T; Von Tress M; Silver LH; Weiner A; Davis AA;
    Am J Ophthalmol; 2001 Dec; 132(6):860-8. PubMed ID: 11730649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.